These drugs are FDA-approved for type 2 diabetes and obesity, but growing evidence supports their use for rheumatoid arthritis, psoriatic arthritis, lupus, osteoarthritis, and metabolic/autoimmune diseases. Who should not take GLP-1 medications
Some people, particularly those still in the titration phase or those sensitive to gastrointestinal effects, report mild increases in nausea
Cualquier protocolo de investigacin combinatoria debe considerar cuidadosamente las posibles superposiciones de seales
November 8, 2023 FDA Approves Zepbound for Weight Management After positive findings from successful clinical trials involving Zepbound for weight management, it was approved by the FDA
If such symptoms occur while on treatment, immediate medical assistance is crucial to address potential complications
International Journal of Molecular Sciences , 25 (8), 4346